Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ClonDoTrial
2024-517537-40-00Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing Clonidin-ratiopharm, Doxacor / Doxazosin STADA and Placebo (3 arms). Primary endpoint: Change in nightmare frequency and intensity (CAPS-IV B2, last week) from baseline to end of treatment. Started Oct 2024; status: completed.
02
Drugs
clonidinedoxazosin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on 2024-517537-40-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517537-40-00.